2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline

C63H36N2O — CID 171051318

IUPAC2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline
SMILESc1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3cccc(-c5ccc6c(c5)c5cccc7oc8cccc6c8c75)c3-4)c2)cc1
InChIInChI=1S/C63H36N2O/c1-2-14-37(15-3-1)38-16-10-17-40(34-38)61-62(65-55-27-9-8-26-54(55)64-61)41-31-33-48-53(36-41)63(50-23-6-4-18-44(50)45-19-5-7-24-51(45)63)52-25-11-20-42(58(48)52)39-30-32-43-46-21-12-28-56-59(46)60-47(49(43)35-39)22-13-29-57(60)66-56/h1-36H
InChIKeyRNFSTFBFUXRBJE-UHFFFAOYSA-N
MW836.99 g/mol
LogP16.28
Rot. Bonds4

About 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline

2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline (PubChem CID 171051318) has the molecular formula C63H36N2O and a molecular weight of 836.99 g/mol. Its IUPAC name is 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline.

Molecular Properties

Compound Name2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline
PubChem CID171051318
Molecular FormulaC63H36N2O
Molecular Weight836.99 g/mol
Exact Mass836.28
IUPAC Name2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline
SMILESc1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3cccc(-c5ccc6c(c5)c5cccc7oc8cccc6c8c75)c3-4)c2)cc1
InChIInChI=1S/C63H36N2O/c1-2-14-37(15-3-1)38-16-10-17-40(34-38)61-62(65-55-27-9-8-26-54(55)64-61)41-31-33-48-53(36-41)63(50-23-6-4-18-44(50)45-19-5-7-24-51(45)63)52-25-11-20-42(58(48)52)39-30-32-43-46-21-12-28-56-59(46)60-47(49(43)35-39)22-13-29-57(60)66-56/h1-36H
InChIKeyRNFSTFBFUXRBJE-UHFFFAOYSA-N
XLogP16.28
TPSA38.92 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms66
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500836.99
LogP ≤ 516.28
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline?
The IUPAC name of 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline (CID 171051318) is 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline.
What is the SMILES notation for 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline?
The canonical SMILES for 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline is c1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc4c(c3)C3(c5ccccc5-c5ccccc53)c3cccc(-c5ccc6c(c5)c5cccc7oc8cccc6c8c75)c3-4)c2)cc1.
What is the InChIKey of 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline?
The InChIKey is RNFSTFBFUXRBJE-UHFFFAOYSA-N. The full InChI is InChI=1S/C63H36N2O/c1-2-14-37(15-3-1)38-16-10-17-40(34-38)61-62(65-55-27-9-8-26-54(55)64-61)41-31-33-48-53(36-41)63(50-23-6-4-18-44(50)45-19-5-7-24-51(45)63)52-25-11-20-42(58(48)52)39-30-32-43-46-21-12-28-56-59(46)60-47(49(43)35-39)22-13-29-57(60)66-56/h1-36H.
What are the key properties of 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline?
2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline has a molecular weight of 836.99 g/mol, XLogP of 16.28, 4 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5'-(19-oxapentacyclo[14.2.1.05,18.06,11.012,17]nonadeca-1,3,5,7,9,11,13,15,17-nonaen-8-yl)-9,9'-spirobi[fluorene]-2'-yl]-3-(3-phenylphenyl)quinoxaline is sourced from PubChem (CID 171051318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).